CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Escitalopram oxalate

Last Updated: June 8, 2006
Result type: Reports
Project Number: SR0064-000
Product Line: Reimbursement Review

Generic Name: Escitalopram oxalate

Brand Name: Cipralex

Manufacturer: Lundbeck Canada Inc.

Therapeutic Area: Depression, Major Depressive Disorder (MDD)

Indications: Depression, Major Depressive Disorder (MDD)

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: January 24, 2007

Recommendation Type: Do not list